Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages
On Jan. 25, 2021, the NIH announced that in large clinical trial conducted worldwide, full dose anti-coagulation (blood…
Full-dose blood thinners decreased need for life support and improved outcome in COVID-19 patients
On Jan. 22, 2021, the NIH announced that in large clinical trial conducted worldwide, full dose anti-coagulation (blood…
NIH researchers identified new genetic disorder that affects brain, craniofacial skeleton
On Jan. 21, 2021, researchers at the NIH announced they had discovered a new genetic disorder characterized by…
A closer look at T cells revealed big differences in mild vs severe COVID-19 cases
On Jan. 21, 2021, NIH researchers announced that after people recover from infection with a virus, the immune…
Blood test showed promise for early detection of acute heart transplant rejection
On Jan. 13, 2021, researchers announced they had developed a blood test that could make it possible for…
NIAID scientists studied salmonella swimming behavior as clues to infection
On Jan. 13, 2021, National Institutes of Health scientists and their colleagues announced they had identified a S….
Audrey Winkelsas researched SMA through the NIH Oxford-Cambridge Scholars Program
On Jan. 4, 2021, Audrey Winkelsas, a 2015 NIH Oxford-Cambridge Scholars Program doctoral student with spinal muscle atrophy…
NIH study uncovered blood vessel damage and inflammation in COVID-19 patientsï¾’ brains but no infection
On Dec. 30, 2020, the NIH researchers announced that an in-depth study of how COVID-19 affects a patientï¾’s…
Peer-reviewed report on Moderna COVID-19 vaccine published
On Dec. 30, 2020, the NIH announced that the investigational vaccine known as mRNA-1273 was 94.1% efficacious in…
Biotechnology | COVID-19 | FDA | Life Science News | NIH | Therapeutics
Medigen Vaccines obtained TFDA phase 2 IND approval for COVID19 vaccine
On Dec. 30, 2020, Medigen Vaccine Biologics announced that it had obtained TFDA Phase 2 IND approval of…
NIH neuroscientists isolated promising mini antibodies against COVID-19 from a llama
On Dec. 22, 2020, the NIH researchers announced they had isolated a set of promising, tiny antibodies, or…
NIH ACTIV Trial of blood thinners paused enrollment of critically ill COVID-19 patients
On Dec. 22, 2020, the NIH researchers announced that three clinical trial platforms working together to test the…
NIH announced support of radical approaches to nationwide COVID-19 testing and surveillance
On Dec. 21, 2020, the NIH announced that it had awarded over $107 million to support new, non-traditional…
NIH funded eight studies to uncover risk factors for COVID-19-related inflammatory syndrome in children
On Dec. 21, 2020, the NIH announced that it had awarded eight research grants to develop approaches for…
Reston Ebolavirus spreads efficiently in pigs
On Dec. 21, 2020, the NIH announced a study published in Proceedings of the National Academy of Sciences…
Meridian received NIH award for supporting rapid development of Revogeneï¾® molecular test for SARS-CoV-2
On Dec. 16, 2020, Meridian Bioscience announced that it had been awarded funding in the amount of approximately…
Moderna updated on clinical development and production of Its COVID-19 vaccine candidate
On Dec. 3, 2020, Moderna announced in a letter to the editor published in the New England Journal…
NIH announced restructured HIV clinical trials networks
On Nov. 30, 2020, The National Institute of Allergy and Infectious Diseases (NIAID) announced the clinical investigators and…
Commonly used antibiotic showed promise for combating Zika infections
On Nov. 24, 2020, preclinical study by the National Institutes of Health (NIH) suggested FDA-approved tetracycline-based antibiotics may…
NIH expanded research to improve COVID-19 testing among underserved and vulnerable populations
On Nov. 20, 2020, the National Institutes of Health (NIH) awarded nearly $45 million to expand the research…
Study of ‘exceptional responders’ yields clues to cancer and potential treatments
On Nov. 19, 2020, in a comprehensive analysis of patients with cancer who had exceptional responses to therapy,…
NIH to fund research of racial disparities in pregnancy-related complications and deaths
On Nov. 17, 2020, the NIH announced funding of new research examining racial and ethnic disparities in pregnancy-related…
Celdara Medical secured funding to develop an adjuvanted universal flu vaccine
On Nov. 17, 2020, Celdara Medical announced that the NIH had awarded a two-year Small Business Innovation Research…
Biotechnology | COVID-19 | Life Science News | NIH | Therapeutics | Vaccine
Moderna’s COVID-19 vaccine candidate met primary endpoint in first interim analysis of phase 3 COVE study
On Nov. 16, 2020, Moderna announced that the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase…
COVID-19 | FDA | Life Science History | NIH
Moderna completed case accrual for first planned interim analysis of mRNA vaccine against COVID-19
On Nov. 11, 2020, Moderna announced that it had completed case accrual for the first interim analysis of…
Biotechnology | HIV | Life Science News | NIH | Therapeutics
Long-acting injectable drug prevented HIV in cisgender women
On Nov. 9, 2020, the NIH reported that a pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form…
Hydroxychloroquine does not benefit adults hospitalized with COVID-19
On Nov. 9, 2020, a National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine…
Single-cell study of Ebola highlighted virus’s lethal maneuvers
On Nov. 6, 2020, in a study published in Cell, the researchers identified antiviral defense genes that the…
Biotechnology | COVID-19 | Life Science News | Medicine | NIH | Therapeutics | Vaccine
Medigen Vaccines and NIHE partnered to develop COVID-19 vaccine in Vietnam
On Nov. 3, 2020, Medigen Vaccine Biologics (MVC) and the National Institute of Hygiene and Epidemiology (NIHE), a…
Final NIH policy for data management and sharing released
On Oct. 29, 2020, the National Institutes of Health (NIH) announed that it will begin requiring most of…